Atlas Venture Life Science Advisors, LLC: 13F holdings
CIK 19175292026Q2
| Positions | 7 |
|---|---|
| Reported value | $881.3m |
| Filed | 2026-08-13 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| KYMR Kymera Therapeutics, Inc. | 2,847,541 | $326.5m | 37.1% |
| DYN Dyne Therapeutics, Inc. | 6,800,099 | $151.0m | 17.1% |
| Sionna Therapeutics, Inc. | 2,995,602 | $131.8m | 15.0% |
| Kailera Therapeutics, Inc. | 5,171,282 | $113.9m | 12.9% |
| Disc Medicine, Inc. | 1,513,875 | $110.7m | 12.6% |
| Q32 Bio, Inc. | 2,717,106 | $34.6m | 3.9% |
| Korro Bio, Inc. | 962,884 | $12.7m | 1.4% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1917529")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.